Sarli, M., Novoa, M. B., Mazzucco Panizza, M. N., Signorini, M., Echaide, I. E., Echaide, S. T. d., & Primo, M. E. (2020). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. PLOS; National Center for Biotechnology Information.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Sarli, Macarena, María Belen Novoa, Matilde Nahimé Mazzucco Panizza, Marcelo Signorini, Ignacio Eduardo Echaide, Susana T. de Echaide, and María Evangelina Primo. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective Against a Virulent Challenge. PLOS; National Center for Biotechnology Information, 2020.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Sarli, Macarena, et al. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective Against a Virulent Challenge. PLOS; National Center for Biotechnology Information, 2020.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.